全文获取类型
收费全文 | 3480篇 |
免费 | 212篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 112篇 |
儿科学 | 50篇 |
妇产科学 | 49篇 |
基础医学 | 615篇 |
口腔科学 | 59篇 |
临床医学 | 314篇 |
内科学 | 694篇 |
皮肤病学 | 54篇 |
神经病学 | 452篇 |
特种医学 | 158篇 |
外科学 | 458篇 |
综合类 | 19篇 |
预防医学 | 133篇 |
眼科学 | 59篇 |
药学 | 233篇 |
肿瘤学 | 242篇 |
出版年
2023年 | 23篇 |
2022年 | 52篇 |
2021年 | 78篇 |
2020年 | 54篇 |
2019年 | 57篇 |
2018年 | 87篇 |
2017年 | 59篇 |
2016年 | 104篇 |
2015年 | 103篇 |
2014年 | 106篇 |
2013年 | 146篇 |
2012年 | 252篇 |
2011年 | 277篇 |
2010年 | 180篇 |
2009年 | 139篇 |
2008年 | 234篇 |
2007年 | 271篇 |
2006年 | 235篇 |
2005年 | 225篇 |
2004年 | 204篇 |
2003年 | 178篇 |
2002年 | 150篇 |
2001年 | 44篇 |
2000年 | 47篇 |
1999年 | 47篇 |
1998年 | 27篇 |
1997年 | 33篇 |
1996年 | 14篇 |
1995年 | 12篇 |
1994年 | 6篇 |
1993年 | 16篇 |
1992年 | 24篇 |
1991年 | 19篇 |
1990年 | 18篇 |
1989年 | 18篇 |
1988年 | 18篇 |
1987年 | 15篇 |
1986年 | 20篇 |
1985年 | 9篇 |
1984年 | 5篇 |
1983年 | 9篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1978年 | 18篇 |
1977年 | 7篇 |
1976年 | 5篇 |
1975年 | 7篇 |
1974年 | 6篇 |
排序方式: 共有3701条查询结果,搜索用时 0 毫秒
1.
2.
Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate—Rapid Tumor Regression Documented by Real Time 3D Echocardiography 下载免费PDF全文
Robert Wagner M.D. Ph.D. Frank Thomas Riede M.D. Hiroshi Seki M.D. Frauke Hornemann M.D. Steffen Syrbe M.D. Ingo Daehnert M.D. Ph.D. Michael Weidenbach M.D. Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(12):1876-1879
The presented case reports on successful treatment with everolimus in a neonate with left ventricular giant rhabdomyoma. The authors used a different dosage regime compared to literature and documented rapid tumor regression by 3D echocardiography. 相似文献
3.
Hans-Peter Schlake Karl-Heinz Grotemeyer Ingolf Böttger Ingo Wilhelm Husstedt Günter Brune 《Neurosurgical review》1987,10(3):191-196
Migraine is considered to be a functional neurological disorder. In classical migraine (headache associated with prodromal visual field disturbances) and migraine accompagnée (headache associated with transient neurological symptoms), disturbances of cerebral blood flow and amine metabolism are thought to be pathogenetic factors. However, conventional methods of neuroimaging (CAT, NMR) usually do not yield any pathological findings in patients. Since 123I-iodoamphetamine (123I-IMP) crosses the intact blood brain barrier, 123I-IMP-SPECT is used for the assessment of cerebral perfusion in various neurological diseases, including functional disorders. 123I-IMP-SPECT was performed on 5 patients with classical migraine and 18 patients with migraine accompagnée. At the time of investigation, all patients were symptom-free. Cerebral blood flow was decreased in all patients with migraine accompagnée, and often corresponded to the site of headache as well as to the topography of transient neurological symptoms. This reduction was most obvious in a patient with persisting neurological symptoms. Most patients with classical migraine, however, did not show any alteration of cerebral perfusion. It appears that migraine--and in particular migraine accompagnée--is characterized by a permanent alteration not only of cerebral blood flow but also of neuronal activity. Migraine attacks may occur in connection with exacerbations of preexisting metabolic alterations. 相似文献
4.
5.
W Peczyńska-Czoch M Mordarski L Kaczmarek P Nantka-Namirski 《Archivum immunologiae et therapiae experimentalis》1987,35(2):89-95
Microbial transformation of selected azacarbazoles, compounds noted for their activity as antitumor agents, conducted with Kitasatosporia setae strain resulted in N-methylation of pyridine nucleus of alpha-, beta- and gamma-carboline molecule. Formed quaternized intermediates were converted in alkaline conditions into corresponding iso-carbolines. The structure of the final products, alpha-, beta- and gamma-iso-carbolines have been established on the basis of spectral data and confirmed by chemical synthesis. 相似文献
6.
Boerhaave’s syndrome: Primary repair vs. esophageal resection—Case reports and meta-analysis of the literature 总被引:3,自引:0,他引:3
Otto Kollmar M.D. Werner Lindemann M.D. Sven Richter M.D. Ingo Steffen M.D. Georg Pistorius M.D. Martin K. Schilling M.D. 《Journal of gastrointestinal surgery》2003,7(6):726-734
Boerhaave’s syndrome is a life-threatening disease with a high mortality. With regard to the heterogeneity of treatment strategies,
no comparative studies exist and recommendations remain controversial. Seventeen cases of Boerhaave’s syndrome operated on
between 1989 and 2000 at our hospital were reviewed retrospectively to compare the time period between perforation and diagnosis,
and the morbidity and mortality among the different treatment options. In addition, we conducted a meta-analysis of the literature
including all series containing five or more patients and compared the findings with our own data. Our patients with a perforation
history of less than 12 hours showed significantly fewer signs of sepsis compared to patients with a history of more than
12 hours. In a comparison of patients with primary repair vs. patients treated with esophageal resection or an exclusion operation,
no differences were found. In the literature, patients with a long period of perforation (more than 24 hours) were treated
more often with an esophageal resection than patients with primary repair. In cases of Boerhaave’s syndrome, primary suturing
of the esophageal perforation should be reserved only for those patients presenting within 12 hours after perforation. In
all other cases, depending on the extent of the tissue damage, a two-stage esophageal resection with cervical esophagostomy
and gastrostomy is recommended as the safest treatment. 相似文献
7.
We treated 6 grade III acromioclavicular injuries with a new fixation method using a bone-ligament transfer of the coracoacromial ligament into a clavicular tunnel. After an average of 16 months, function and cosmesis were excellent in all patients. 相似文献
8.
Jan Groetzner Ingo Kaczmarek Bruno Meiser Markus Müller Sabine Daebritz Bruno Reichart 《The Journal of heart and lung transplantation》2004,23(6):770-773
Chronic renal failure triggered by calcineurin inhibitor (CNI)-based immunosuppression is a common complication after cardiac transplantation. Sirolimus and mycophenolate mofetil (MMF) are 2 newer immunosuppressive agents with no documented nephrotoxic side effects. This case report describes a patient with ongoing chronic renal failure 10 months after cardiac transplantation on cyclosporine-based immunosuppressive therapy. Conversion of the immunosuppressive regimen from cyclosporine to sirolimus and MMF resulted in freedom from acute rejection, excellent cardiac graft function and consistently improved renal function. This case illustrates the beneficial potential of sirolimus and MMF as CNI-free and safe long-term immunosuppression in a patient with chronic renal failure after heart transplantation. 相似文献
9.
10.